Executive Education - Creating Early Stage IP Value in Life Sciences

In today’s competitive life sciences landscape, breakthrough science is just the beginning. This executive seminar shows how to transform early-stage innovation into structured, investable value by integrating Target Product Profile (TPP) thinking and strategic IP management from day one.

You will discover how an early-defined TPP aligns scientific, regulatory and commercial priorities, while a thoughtfully structured IP portfolio strengthens competitive advantage, partnership opportunities, and long-term enterprise value. Through practical insights and forward-looking strategies, this session equips leaders, founders and investors with the tools to turn scientific potential into globally scalable, value-generating platforms.

Invest in your knowledge. Shape innovation that matters.